Hypoxia-inducible factor 1α (HIF-1α) is the main transcription factor involved in the adaptation to hypoxic environments in cancer cells, contributing to the regulation of metabolism, angiogenesis, cell survival, and drug resistance (3), thus making it an appealing target for tumor therapy. The gene discussed is HIF1A; the disease is cancer.